Mathias Färnegårdh, Ph.D.
Founder and CSO

Has two decades of experience of leadership in drug discovery, initiating and driving innovative projects with international partners. He has an in depth understanding of target biology and a particular interest in immunology.

Konrad Koehler, Ph.D.
Founder and Principal Scientist Medicinal Chemistry

Over 25 years’ experience in drug discovery at Searle R&D, Merck Italia, Solvay Pharmaceuticals GmbH, Karo Bio AB, and Beactica AB instrumental in establishing drug discovery collaborations with which resulted in four drug candidates that underwent clinical trials.

Lars Öhman
Founder and CEO

Lars has a proven track record in drug discovery and business development within the pharmaceutical industry with over 25 years wide-ranging research and business experience in senior positions at Karo Bio AB following several years at Pharmacia.